EMTAF-B TABLETS

Name: EMTAF-B TABLETS
Brand: Ingram Biosciences Pvt. Ltd.
Price: 809.0 INR
Availability: InStock

Price 809.0 INR/ Piece

Get a Price/Quote

EMTAF-B TABLETS Specification

Salt Composition
TENOHEP-AF ALAFENAMIDE TABLETS IP 25 MG

Pacakaging (Quantity Per Box)
30

Origin of Medicine
INDIA

Indication
Hepatitis

Dosage Form
ONCE-A-DAY

Drug Type
Other

Ingredients
EMTAF-B TABLETS contain the antiviral medication Tenofovir alafenamide (TAF). They are primarily used to treat chronic (long-term) Hepatitis B virus (HBV) infection in adults and adolescents aged 12 and older. It may also be used in combination with other antiretroviral medicines for HIV-1 infection. Key functions Mechanism of action: Tenofovir alafenamide works by inhibiting the viral enzyme reverse transcriptase. This prevents the hepatitis B virus and HIV from replicating and multiplying in the body, which helps to reduce the viral load and clear the infection. Safety profile: TAF is known to have improved kidney and bone safety compared to older formulations of tenofovir (TDF). Uses and dosage Primary use: Treatment of chronic Hepatitis B virus (HBV) infection. Secondary use: Treatment of HIV-1 infection, always in combination with other antiretroviral medications. Dosage: As directed by a physician, typically one 25 mg tablet taken orally once daily. It is generally recommended to take it with food to increase absorption. Important considerations: Do not stop taking the medication without consulting your doctor, as this can worsen your condition. For HIV treatment, it is always used as part of a combination therapy and is not a cure. Potential side effects Common side effects of EMTAF-B include: Headache Diarrhea Nausea and vomiting Abdominal or joint pain Dizziness and fatigue Rash or itching Less common but serious side effects can include worsening kidney impairment, liver problems, and lactic acidosis (a buildup of lactic acid in the blood). Warnings and precautions Medical history: Inform your doctor if you have kidney or liver disease, HIV infection, or are intolerant to certain sugars. Monitoring: Regular blood tests are necessary to monitor liver and kidney function and viral levels during treatment. Pregnancy and breastfeeding: Use with caution during pregnancy and is generally not recommended for breastfeeding women. Consultation with a doctor is necessary. Driving: Avoid driving or operating heavy machinery if you experience dizziness or drowsiness. Alcohol: Avoid drinking alcohol, as it can increase the risk of liver damage. Infection transmission: The medication does not prevent the spread of HBV or HIV to others through sexual contact or blood contamination. Safe practices are still necessary.

Physical Form
Tablets

Function
Other

Dosage
ONCE-A-DAY

Dosage Guidelines
AS PER DIOCTOR ADVICE

Suitable For
Women, Adults, Aged Person

Quantity
1 Pieces

Storage Instructions
ROOM TEMPERATURE

EMTAF-B TABLETS Trade Information

Minimum Order Quantity
2 Pieces

FOB Port
NEW DELHI

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Pieces Per Day

Delivery Time
3 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
1*30

Main Export Market(s)
Asia

Main Domestic Market
All India

About EMTAF-B TABLETS

EMTAF-B TABLETS contain the antiviral medication Tenofovir alafenamide (TAF). They are primarily used to treat chronic (long-term) Hepatitis B virus (HBV) infection in adults and adolescents aged 12 and older. It may also be used in combination with other antiretroviral medicines for HIV-1 infection.

Key functions

Mechanism of action: Tenofovir alafenamide works by inhibiting the viral enzyme reverse transcriptase. This prevents the hepatitis B virus and HIV from replicating and multiplying in the body, which helps to reduce the viral load and clear the infection.
Safety profile: TAF is known to have improved kidney and bone safety compared to older formulations of tenofovir (TDF).

Uses and dosage

Primary use: Treatment of chronic Hepatitis B virus (HBV) infection.
Secondary use: Treatment of HIV-1 infection, always in combination with other antiretroviral medications.
Dosage: As directed by a physician, typically one 25 mg tablet taken orally once daily. It is generally recommended to take it with food to increase absorption.
Important considerations:
- Do not stop taking the medication without consulting your doctor, as this can worsen your condition.
- For HIV treatment, it is always used as part of a combination therapy and is not a cure.

Potential side effects

Common side effects of EMTAF-B include:

Headache
Diarrhea
Nausea and vomiting
Abdominal or joint pain
Dizziness and fatigue
Rash or itching

Less common but serious side effects can include worsening kidney impairment, liver problems, and lactic acidosis (a buildup of lactic acid in the blood).

Warnings and precautions

Medical history: Inform your doctor if you have kidney or liver disease, HIV infection, or are intolerant to certain sugars.
Monitoring: Regular blood tests are necessary to monitor liver and kidney function and viral levels during treatment.
Pregnancy and breastfeeding: Use with caution during pregnancy and is generally not recommended for breastfeeding women. Consultation with a doctor is necessary.
Driving: Avoid driving or operating heavy machinery if you experience dizziness or drowsiness.
Alcohol: Avoid drinking alcohol, as it can increase the risk of liver damage.
Infection transmission: The medication does not prevent the spread of HBV or HIV to others through sexual contact or blood contamination. Safe practices are still necessary.